5'-O-Phosphonomethyl-2',3'-dideoxynucleosides: synthesis and anti-HIV activity

Authors:

Abstract
5''-O-Phosphonomethylation of different pyrimidine 2'',3''-dideoxynucleosides was accomplished by reaction of the latter with diethyl [(p-tolylsulfonyl)oxy]methanephosphonate (1) in the presence of sodium hydride. The base-phosphonomethylated (15-19) and sugar-phosphonomethylated (8-12) derivatives could be readily distinguished by 1H and 13C NMR and MS analysis. Protection of the uracil or thymine residue with a N3-benzoyl group failed to prevent base modification. However, O4-methyl-protected 2'',3''-dideoxyuridine readily afforded the 5''-O-phosphonomethylated derivative 12, which was converted to both the 2'',3''-dideoxyuridine analogue 27 and the 2'',3''-dideoxycytidine counterpart 29. The 5''-O-phosphonomethyl derivatives of 3''-deoxythymidine (23), 2'',3''-dideoxyuridine (27), 2'',3''-dideoxycytidine (29), 3''-O-methylthymidine (26), and 3''-amino-3''-deoxythymidine (28) did not show an appreciable anti-HIV activity in MT-4 cells. In contrast, the 5''-O-phosphonomethyl derivatives of 3''-deoxy-3''-fluorothymidine (24) and 3''-azido-3''-deoxythymidine (25) inhibited HIV-1 cytopathogenicity by 50% at a concentration of approximately 1 .mu.M.

This publication has 15 references indexed in Scilit: